Skip to main navigation Skip to search Skip to main content

Serum sickness with acquired precipitating antibodies during rush immunotherapy (2 cases)

  • M. H. Chabane
  • , F. Leynadier
  • , G. M. Halpern
  • , J. Dry

Research output: Journal Publications and ReviewsRGC 22 - Publication in policy or professional journal

Abstract

Serum sickness can be induced by several heterologous proteins. Two patients undergoing rush immunotherapy developed clinical symptoms of serum sickness. One patient received a mite and grass pollens mixture and the second patient a wasp and yellow-jacket venoms mixture. Precipitating antibodies against some allergens used for immunotherapy were found in their serum during the disease but not in the sera drawn before immunotherapy and two and three months after. Pathologic findings showed a leukocytoclastic vasculitis. Pathogenesis of this complication is discussed.
Original languageEnglish
Pages (from-to)216-219
JournalAnnals of Allergy
Volume61
Issue number3
Publication statusPublished - 1988
Externally publishedYes

Fingerprint

Dive into the research topics of 'Serum sickness with acquired precipitating antibodies during rush immunotherapy (2 cases)'. Together they form a unique fingerprint.

Cite this